FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0

R Boellaard, R Delgado-Bolton, WJG Oyen… - European journal of …, 2015 - Springer
The purpose of these guidelines is to assist physicians in recommending, performing,
interpreting and reporting the results of FDG PET/CT for oncological imaging of adult …

PET/MRI: where might it replace PET/CT?

EC Ehman, GB Johnson… - Journal of Magnetic …, 2017 - Wiley Online Library
Simultaneous positron emission tomography and MRI (PET/MRI) is a technology that
combines the anatomic and quantitative strengths of MR imaging with physiologic …

Early positron emission tomography response–adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC/LYSA/FIL H10 trial

MPE André, T Girinsky, M Federico… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Patients who receive combined modality treatment for stage I and II Hodgkin
lymphoma (HL) have an excellent outcome. Early response evaluation with positron …

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification

BD Cheson, RI Fisher, SF Barrington… - Journal of clinical …, 2014 - ascopubs.org
The purpose of this work was to modernize recommendations for evaluation, staging, and
response assessment of patients with Hodgkin lymphoma (HL) and non-Hodgkin lymphoma …

Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group

SF Barrington, NG Mikhaeel, L Kostakoglu… - Journal of clinical …, 2014 - ascopubs.org
Purpose Recent advances in imaging, use of prognostic indices, and molecular profiling
techniques have the potential to improve disease characterization and outcomes in …

Deep auto-context convolutional neural networks for standard-dose PET image estimation from low-dose PET/MRI

L **ang, Y Qiao, D Nie, L An, W Lin, Q Wang, D Shen - Neurocomputing, 2017 - Elsevier
Positron emission tomography (PET) is an essential technique in many clinical applications
such as tumor detection and brain disorder diagnosis. In order to obtain high-quality PET …

Non-hodgkin lymphoma

KR Shankland, JO Armitage, BW Hancock - The Lancet, 2012 - thelancet.com
Lymphomas are solid tumours of the immune system. Hodgkin's lymphoma accounts for
about 10% of all lymphomas, and the remaining 90% are referred to as non-Hodgkin …

From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors

RL Wahl, H Jacene, Y Kasamon… - Journal of nuclear …, 2009 - jnm.snmjournals.org
The purpose of this article is to review the status and limitations of anatomic tumor response
metrics including the World Health Organization (WHO) criteria, the Response Evaluation …

Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma

AS LaCasce, RG Bociek, A Sawas… - Blood, The Journal …, 2018 - ashpublications.org
Autologous stem cell transplantation (ASCT) is standard of care for patients with Hodgkin
lymphoma (HL) who have relapsed/refractory disease after frontline chemotherapy …

Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma

K Dunleavy, S Pittaluga, LS Maeda… - … England Journal of …, 2013 - Mass Medical Soc
Background Primary mediastinal B-cell lymphoma is a distinct subtype of diffuse large-B-cell
lymphoma that is closely related to nodular sclerosing Hodgkin's lymphoma. Patients are …